- Home
- Services
- usa massachusetts
- biomarker development
Refine by
Biomarker Development Services Available In Massachusetts
32 services found
Manufactured by:Nexelis based inSeattle, WASHINGTON (USA)
Testing Services to Support Your Preclinical and Phase I-IV Drug Programs. Nexelis, a Q² Solutions Company, provides biomarker assay services in inflammation and immunology, oncology, organ injury (renal), nutritional health, cardiovascular, metabolic (NASH/NAFLD) and infectious diseases. Our scientists approach your projects with flexible and creative solutions, ...
Manufactured by:Advanced Cell Diagnostics, Inc. based inNewark, CALIFORNIA (USA)
ACD's Professional Assay Services group has been developing RNAscope™ biomarker assays for our biopharma partners for a decade. Our biomarker assays have contributed to important clinical trial exploratory endpoints, enabled more accurate patient selection, and are leading to CDx development with our partner, Leica ...
Manufactured by:Firalis Group based inHuningue, FRANCE
The successful implementation of a biomarker endpoint is highly dependent on the availability of assays and on reliable measurements of markers in biological samples. While a large number of assays are on the market, scientists often have an urgent need for assays meeting specific ...
Manufactured by:Advanced Cell Diagnostics, Inc. based inNewark, CALIFORNIA (USA)
There is growing interest in RNA-based biomarkers and measuring RNA expression holds great promise for stratifying patients based on drug response, drug efficacy and risk of side effects. RNAscope in situ hybridization enables molecular detection in a morphological context. It provides the cellular resolution required to evaluate tissue heterogeneity and to potentially better screen and select ...
by:Flagship Biosciences Inc. based inBroomfield, COLORADO (USA)
Expertise in pathology, biology, image analysis, data science, artificial intelligence and assay development. What does your tissue data mean for your development program? What are the next steps in using a tissue data solution for your clinical trial? How do you move forward with a patient selection strategy? Flagship’s team of experts will work with you ...
by:Eurofins Scientific based inKraainem, BELGIUM
Complete preclinical service: Early and full drug development is regulatory-driven and complex. The priority in this selection process is to achieve the safety and efficacy of a new molecular entity. The preclinical activity includes mainly safety and pharmacological testing accompanied by metabolism, bioanalysis, biomarker development and ...
Manufactured by:Eleven P15 based inDenver, COLORADO (USA)
Eleven P15 focuses on the development of biomarkers that enable early detection of idiopathic pulmonary fibrosis, and the discovery of genetically-targeted therapeutic approaches to treat and prevent this incurable ...
by:PhenoPath, PLLC based inSeattle, WASHINGTON (USA)
Optimization and validation services for use in biomarker discovery, drug development, diagnosis, and clinical trial applications on human, animal, and xenograph samples. More than 20 years of ...
Manufactured by:Advanced Brain Monitoring, Inc. based inCarlsbad, CALIFORNIA (USA)
Stat X24 combines rapid application, low patient burden and disposable materials with high quality EEG acquisition easily performed in a clinical or home setting. Our team has expertise in customized quantitative EEG analysis, biomarker development and implementation, and support of international investigational drug clinical trials. Biomarker ...
Manufactured by:Elpiscience based inShanghai, CHINA
Elpiscience leverages our deep understanding of tumor biology and mechanisms of action to translate target biology for challenging pathways, develop biomarkers and strategically select indications and patients for clinical studies. We apply cutting-edge technologies including gene editing for target screening, single cell sequencing and advanced bioinformatics ...
Manufactured by:Exosome Diagnostics, Inc. based inWaltham, MASSACHUSETTS (USA)
After marker identification, biomarkers and/or gene signatures enter our development process to become targeted assays. The newly identified biomarkers are developed into a Laboratory Developed Test (LDT) that will be run in Exosome Diagnostic’s CLIA and CAP accredited ...
by:Activation Laboratories Ltd. based inAncaster, ONTARIO (CANADA)
ActLabs Biotech scientists can assist with innovative biomarker assay development and validation. To compliment our range of immunoassays, we also offer LC-MS/MS technology that has enabled us to extend our portfolio to include more biomarkers. In addition, we have invested in the field of multiplexing, using a bead-based suspension and ...
by:SGS M-SCAN Ltd based inWokingham, UNITED KINGDOM
In collaboration with the clinical team, SGS has actively pursued innovative biomarker assay development and validation. To complement our range of immunoassays, we are now offering LC-MS/MS technology that has enabled us to extend our portfolio to include more biomarkers such as steroidal and hormonal substances in the low picogram range. ...
Manufactured by:AgPlus Diagnostics Ltd based inSharnbrook, UNITED KINGDOM
We are proud to have developed a tried and tested B2B commercial approach. We strive to progress partnerships including technology licensing, assay development plus manufacture and supply, with collaborators in a variety of applications and business ...
Manufactured by:BioSensics LLC based inNewton, MASSACHUSETTS (USA)
BioSensics provides comprehensive technical and scientific consulting services to help meet your specific ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Veracyte’s professional framework for clinical trial assay (CTA) and companion diagnostics (CDx) development allows our clients to confidently advance priority projects. With an end-to-end service infrastructure, we support all aspects of assay development, manufacturing, life cycle management, regulatory submissions, marketing support, and commercialization for our ...
Manufactured by:GENCURIX based inGuro-gu, SOUTH KOREA
Gencurix R&D Center is performing ceaseless research activities to developing the ‘multiplex assay’ which is core technology for economy in expenditures, time and samples. We have accumulated research capabilities and experiences of entire development process of molecular diagnostic ...
Manufactured by:Cellworks Research India Private Limited based inBangalore, INDIA
Accelerate drug development timelines, reduce risks and lower costs. Our biosimulation platform predicts human clinical response to investigational drug candidates YEARS earlier than traditional development ...
by:Biodesix based inBoulder, COLORADO (USA)
We strive to hold ourselves to the highest quality standard so we can arm our biopharma partners with superior diagnostic solutions to overcome the challenges and risks associated with drug discovery, development and commercialization through strategic companion diagnostic (CDx) ...
by:Indivumed GmbH based inHamburg, GERMANY
Biomarkers are important when it comes to the development of novel drugs and mechanisms and are also gaining importance as companion diagnostic ...